HealthSouth's (HLS) Non-Aggressive 2016 Outlook is as Expected - Mizuho Securities Reiterates Buy
Tweet Send to a Friend
Mizuho Securities reiterated a Buy rating and $40.00 price target on HealthSouth (NYSE: HLS) after the company reiterated its 2015 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
